GlassScriptPhysician profile
Christa Jackson
NPI 1760791230
$768.85
in general payments reported to CMS, 2019-2025
16 companies · $323 in 2025
The $323 reported for 2025 was more than what 90% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $52.43 · 2022: $57.98 · 2023: $219 · 2024: $116 · 2025: $323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $658.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $227.33 | 2021-2025 | |
| Alkermes, INC. | $84.98 | 2023-2025 | Aristada, Lybalvi, Vivitrol |
| Abbott Laboratories | $68.14 | 2023 | Ensite |
| Otsuka America Pharmaceutical, INC. | $63.68 | 2023-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Lundbeck LLC | $59.89 | 2025 | Rexulti |
| Biogen, INC. | $58.02 | 2025 | Zurzuvae |
| Corium, LLC | $39.15 | 2024 | Azstarys |
| Agile Therapeutics, INC. | $32.62 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $26.29 | 2024 | Caplyta |
| Exeltis, USA INC. | $22.91 | 2023 | Slynd |
| Pfizer INC. | $18.45 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.82 | 2024 | Trintellix |
| Neurocrine Biosciences, INC. | $14.66 | 2023 | Ingrezza |
| Scynexis, INC. | $13.22 | 2022 | |
| Astellas Pharma US INC | $12.94 | 2023 | Veozah |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $11.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christa Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.